This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
New Strong Sell Stocks for August 29th
by Zacks Equity Research
CCCS, CYH, and EQX have been added to the Zacks Rank #5 (Strong Sell) List on August 29, 2022.
Community Health (CYH) Down 30.3% Since Q2 Earnings Report
by Zacks Equity Research
Community Health (CYH) expects capex to remain within $400-$450 million in 2022.
Implied Volatility Surging for Community Health (CYH) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Community Health (CYH) stock based on the movements in the options market lately.
Community Health Systems (CYH) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of -25,100% and 6.60%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Universal Health Services (UHS) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of 5.77% and 0.08%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
HCA Healthcare (HCA) Beats Q2 Earnings Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 14.71% and 0.31%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Tenet Healthcare (THC) Q2 Earnings Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 108.33% and 4.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Community Health Systems (CYH) Q2 Earnings Expected to Decline
by Zacks Equity Research
Community Health Systems (CYH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Select Medical (SEM) Stock is a Strong Buy Now
by Zacks Equity Research
Strategic alliances are bolstering Select Medical's (SEM) growth potential while mitigating the risk factor.
Do Options Traders Know Something About Community Health (CYH) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Community Health (CYH) stock based on the movements in the options market lately.
Select Medical (SEM) Inks JV to Serve Venice and Nearby Areas
by Zacks Equity Research
Select Medical (SEM) teams up with Community Health's arm, ShorePoint Health Venice, for jointly operating a hospital dedicated to serve post-acute care needs of patients.
Why Is Community Health Systems (CYH) Down 36.9% Since Last Earnings Report?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Encompass Health (EHC) Unveils Plan to Better Serve Texas
by Zacks Equity Research
Encompass Health (EHC) announces plans to construct a 60-bed inpatient rehabilitation hospital in Texas in a bid to more effectively cater to the health issues of the state.
Community Health (CYH) Boosts Obstetrics Care With Technology
by Zacks Equity Research
Community Health (CYH) employs PeriGen's technology to bring about enhanced obstetrics services and assure the safety of mothers as well as babies in the labor and delivery procedures.
Why Acadia Healthcare (ACHC) Dips 1.6% Despite Q1 Earnings Beat
by Zacks Equity Research
Acadia Healthcare (ACHC) aims to add around 300 beds to its existing facilities in 2022.
Cigna (CI) Q1 Earnings Beat on High Membership, Ups '22 EPS View
by Zacks Equity Research
Cigna's (CI) first-quarter results gain momentum from strong performances in Evernorth and Cigna Healthcare segments. A raised EPS outlook for 2022 remains noteworthy.
Community Health (CYH) Q1 Earnings Beat, Trims '22 EPS View
by Zacks Equity Research
Community Health's (CYH) first-quarter results benefit on the back of higher adjusted admissions and reduced interest expense. A lowered 2022 outlook for EPS might be a concern for investors.
Community Health Systems (CYH) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of 7.69% and 1.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Encompass Health (EHC) Relocates North Alabama Hospital
by Zacks Equity Research
Encompass Health (EHC) commences operations in its North Alabama hospital, which has been relocated with added capacity for better serving residents of the Huntsville community.
Ensign Group (ENSG) on Buyout Spree, Adds New Properties
by Zacks Equity Research
Ensign Group (ENSG) acquires the operations of certain living facilities in California and Washington to bolster its portfolio.
Community Health Systems (CYH) Down 4.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain Community Health (CYH) Stock
by Zacks Equity Research
With contract labor headwinds likely to phase out as 2022 progresses, Community Health Systems' (CYH) margins are set to improve significantly.
Encompass Health (EHC) Inaugurates New Hospital in Florida
by Zacks Equity Research
Encompass Health (EHC) increases its nationwide inpatient rehabilitation hospital count to 147 with the recently inaugurated 40-bed hospital in St. Augustine, FL.
Acadia Healthcare (ACHC) Q4 Earnings Miss on High Operating Costs
by Zacks Equity Research
Acadia Healthcare (ACHC) anticipates earnings per share within 62-66 cents for the March quarter of 2022.
Encompass Health (EHC) Ties Up to Better Serve Florida Residents
by Zacks Equity Research
Encompass Health (EHC) joins forces with Lee Health in a bid to construct two inpatient rehabilitation hospitals in Southwest Florida and deliver better health outcomes across the region.